p53 exon 5 mutations as a prognostic indicator of shortened survival in non-small-cell lung cancer
- 1 July 1997
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 76 (1) , 44-51
- https://doi.org/10.1038/bjc.1997.334
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Frequent TP53 gene alterations (mutation, allelic loss, nuclear accumulation) in primary non-small cell lung CancerEuropean Journal Of Cancer, 1996
- Immunohistochemical detection of p53 protein is not associated with a poor prognosis in non-small-cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1995
- p53 protein accumulation in European hepatocellular carcinoma is not always dependent on p53 gene mutationGastroenterology, 1995
- Comparative analysis of p53 gene mutations and protein accumulation in human non‐small‐cell lung cancerInternational Journal of Cancer, 1995
- Flexibility: the key to p53 function?Trends in Biochemical Sciences, 1995
- p53 in Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- What the papers say: p53 Loss of Function: Implications for the Processes of Immortalization and TumorigenesisBioEssays, 1992
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981